U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C9H15NO4S
Molecular Weight 233.285
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NV-354

SMILES

COC(=O)CCC(=O)SCCNC(C)=O

InChI

InChIKey=LCEITCPWQIJXGQ-UHFFFAOYSA-N
InChI=1S/C9H15NO4S/c1-7(11)10-5-6-15-9(13)4-3-8(12)14-2/h3-6H2,1-2H3,(H,10,11)

HIDE SMILES / InChI

Molecular Formula C9H15NO4S
Molecular Weight 233.285
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 19:55:17 GMT 2023
Edited
by admin
on Sat Dec 16 19:55:17 GMT 2023
Record UNII
4GF65YYK2S
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NV-354
Common Name English
NV354
Code English
Butanoic acid, 4-[[2-(acetylamino)ethyl]thio]-4-oxo-, methyl ester
Common Name English
Methyl 4-{[2-(acetamino)ethyl]sulfanyl}-4-oxobutanoate
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 933323
Created by admin on Sat Dec 16 19:55:17 GMT 2023 , Edited by admin on Sat Dec 16 19:55:17 GMT 2023
Code System Code Type Description
CAS
866465-21-6
Created by admin on Sat Dec 16 19:55:17 GMT 2023 , Edited by admin on Sat Dec 16 19:55:17 GMT 2023
PRIMARY
FDA UNII
4GF65YYK2S
Created by admin on Sat Dec 16 19:55:17 GMT 2023 , Edited by admin on Sat Dec 16 19:55:17 GMT 2023
PRIMARY
PUBCHEM
86075622
Created by admin on Sat Dec 16 19:55:17 GMT 2023 , Edited by admin on Sat Dec 16 19:55:17 GMT 2023
PRIMARY
Related Record Type Details
METABOLITE ACTIVE -> PRODRUG
Developed for chronic oral treatment of Leigh syndrome, a severe primary mitochondrial disease that usually debuts at one to two years of age.
Name Property Type Amount Referenced Substance Defining Parameters References
BRAIN/PLASMA RATIO PHARMACOKINETIC